Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial - Smith, M; Parker, C; Saad, F (The Lancet Oncology, 2019)
. doi:10.1016/S1470-2045(18)30860-X